Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder

Alcohol-related liver disease is a public health care burden globally. Only 10–20% of patients with alcohol use disorder have progressive liver disease. This study aimed to identify lipid biomarkers for the early identification of progressive alcohol-related liver disease, which is a key step for ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Bei, Zeng, Suling, Maccioni, Luca, Shi, Xiaochun, Armando, Aaron, Quehenberger, Oswald, Zhang, Xinlian, Stärkel, Peter, Schnabl, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146183/
https://www.ncbi.nlm.nih.gov/pubmed/35629937
http://dx.doi.org/10.3390/metabo12050433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146183/
https://www.ncbi.nlm.nih.gov/pubmed/35629937
http://dx.doi.org/10.3390/metabo12050433

Ejemplares similares